EYPT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.74%

Insider Buying (Last 12 Months): $89,515,138.62

Insider Selling (Last 12 Months): $45,265,564.57

EyePoint Pharmaceuticals Insider Trading History Chart

EyePoint Pharmaceuticals Share Price & Price History

^$8.91

▲ +0.13 (1.48%)

As of 09/18/2024 01:00 AM ET

Days: 30 | 90 | 365

China Stockpiling Gold “Like No Tomorrow”

From True Gold Republic | Ad

For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .

Click here now to get your free 'De-Dollarization' Guide.

EyePoint Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/20/2024	Wendy F Dicicco	Director	Buy	2,567	$7.79	$19,996.93	9,967
7/12/2024	David R Guyer	Director	Sell	11,625	$10.06	$116,947.50	1,850
5/14/2024	David R Guyer	Director	Sell	11,625	$12.65	$147,056.25	5,550
5/6/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	850,000	$11.86	$10,081,000.00	8,325,000
4/18/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	581,765	$18.03	$10,489,222.95	7,475,000
2/2/2024	David Scott Jones	SVP	Sell	209	$28.49	$5,954.41	37,962
1/26/2024	Dario A Paggiarino	Insider	Sell	49,325	$25.66	$1,265,679.50	36,505
1/25/2024	David Scott Jones	SVP	Sell	600	$25.00	$15,000.00	37,962
1/23/2024	Dario A Paggiarino	Insider	Sell	5,135	$25.00	$128,375.00	36,505
1/23/2024	David Scott Jones	SVP	Sell	900	$25.00	$22,500.00	37,962
1/11/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	750,000	$19.75	$14,812,500.00	6,893,235
1/11/2024	Ye Liu	Director	Sell	1,910,500	$19.45	$37,159,225.00	100,221
1/9/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	105,000	$21.32	$2,238,600.00	6,143,235
1/8/2024	Dario A Paggiarino	Insider	Sell	22,913	$21.13	$484,151.69	36,505
12/13/2023	Dario A Paggiarino	Insider	Sell	1,458	$20.00	$29,160.00	25,707
12/8/2023	Cormorant Asset Management, Lp	Major Shareholder	Buy	588,235	$17.00	$9,999,995.00	6,038,235
12/6/2023	Ye Liu	Director	Sell	266,242	$18.41	$4,901,515.22	2,010,721
12/4/2023	Cormorant Asset Management, Lp	Major Shareholder	Buy	1,919,057	$21.82	$41,873,823.74	5,450,000
12/4/2023	Michael Craig Pine	Insider	Sell	45,000	$22.00	$990,000.00	5,343
9/1/2023	Ew Healthcare Partners, L.P.	Major Shareholder	Sell	20,000	$9.90	$198,000.00	3,490,921
8/30/2023	Ew Healthcare Partners, L.P.	Major Shareholder	Sell	60,976	$10.92	$665,857.92	3,589,416
8/28/2023	Ew Healthcare Partners, L.P.	Major Shareholder	Sell	60,858	$11.71	$712,647.18	3,738,246
8/24/2023	Ew Healthcare Partners, L.P.	Major Shareholder	Sell	139,280	$14.62	$2,036,273.60	3,883,760
8/22/2023	Ew Healthcare Partners, L.P.	Major Shareholder	Sell	46,778	$14.62	$683,894.36	4,144,143
5/30/2023	Ye Liu	Director	Sell	1	$6.00	$6.00	3,010,721

Unlock the Secret to Easy Wins with Iron Condors

From Netpicks | Ad

Discover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consistently without needing a large account or watching the market all day. Our free report, The Top 10 Stocks for Iron Condor Trades, reveals exactly how to set up winning trades with minimal downside.

Download Your FREE Iron Condor Guide Now

SEC Filings (Institutional Ownership Changes) for EyePoint Pharmaceuticals (NASDAQ:EYPT)

99.41% of EyePoint Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

EyePoint Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/16/2024	Point72 DIFC Ltd	3,962	$34K	0.0%	-23.8%	0.007%
8/19/2024	Fiera Capital Corp	677,038	$5.89M	0.0%	+0.9%	1.300%
8/19/2024	Point72 Asset Management L.P.	630,769	$5.49M	0.0%	N/A	1.211%
8/16/2024	Perceptive Advisors LLC	640,274	$5.57M	0.1%	+8.6%	1.229%
8/15/2024	The Manufacturers Life Insurance Company	68,043	$0.59M	0.0%	-11.1%	0.131%
8/15/2024	Millennium Management LLC	580,716	$5.05M	0.0%	-71.6%	1.115%
8/15/2024	Deerfield Management Company L.P. Series C	877,790	$7.64M	0.1%	+51.4%	1.685%
8/15/2024	AQR Capital Management LLC	28,723	$0.25M	0.0%	-51.4%	0.054%
8/14/2024	Squarepoint Ops LLC	46,456	$0.40M	0.0%	-66.5%	0.087%
8/14/2024	Cubist Systematic Strategies LLC	476,250	$4.14M	0.0%	+842.5%	0.890%
8/14/2024	Profund Advisors LLC	12,793	$0.11M	0.0%	-16.6%	0.025%
8/13/2024	Canada Pension Plan Investment Board	15,600	$0.14M	0.0%	-88.0%	0.030%
8/9/2024	Renaissance Technologies LLC	152,800	$1.33M	0.0%	+112.5%	0.293%
8/9/2024	Dimensional Fund Advisors LP	28,447	$0.25M	0.0%	-3.9%	0.055%
8/9/2024	Greenwich Wealth Management LLC	10,800	$94K	0.0%	N/A	0.021%
8/8/2024	Federated Hermes Inc.	290,212	$2.53M	0.0%	-54.9%	0.557%
8/6/2024	Quest Partners LLC	8,905	$77K	0.0%	-66.9%	0.017%
8/5/2024	Arizona State Retirement System	13,251	$0.12M	0.0%	+9.7%	0.025%
8/3/2024	TD Asset Management Inc	127,694	$1.11M	0.0%	-10.6%	0.245%
8/1/2024	Fiera Capital Corp	677,038	$5.89M	0.0%	+0.9%	1.300%
8/1/2024	Rhumbline Advisers	76,833	$0.67M	0.0%	+32.6%	0.148%
7/29/2024	Panagora Asset Management Inc.	120,721	$1.05M	0.0%	+205.5%	0.232%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	10,888	$95K	0.0%	+271.0%	0.021%
7/26/2024	Legato Capital Management LLC	19,437	$0.17M	0.0%	-72.9%	0.037%
7/26/2024	Bank of New York Mellon Corp	204,892	$1.78M	0.0%	+32.6%	0.393%
7/12/2024	SG Americas Securities LLC	76,288	$0.66M	0.0%	N/A	0.146%
7/8/2024	Woodstock Corp	55,387	$0.48M	0.0%	+80.0%	0.106%
5/20/2024	Virtu Financial LLC	11,639	$0.24M	0.0%	N/A	0.022%
5/17/2024	RA Capital Management L.P.	938,591	$19.40M	0.2%	N/A	1.802%
5/16/2024	California State Teachers Retirement System	43,275	$0.89M	0.0%	+884.2%	0.083%
5/16/2024	Janus Henderson Group PLC	26,856	$0.56M	0.0%	N/A	0.052%
5/15/2024	Price T Rowe Associates Inc. MD	2,465,815	$50.97M	0.0%	-2.3%	4.735%
5/14/2024	American International Group Inc.	18,378	$0.38M	0.0%	+38.4%	0.035%
5/13/2024	Ameritas Investment Partners Inc.	3,719	$77K	0.0%	+44.0%	0.007%
5/10/2024	Vanguard Group Inc.	2,396,228	$49.53M	0.0%	+17.8%	4.601%
5/9/2024	Lord Abbett & CO. LLC	242,580	$5.02M	0.0%	-34.6%	0.466%
5/8/2024	Entropy Technologies LP	13,512	$0.28M	0.0%	N/A	0.026%
5/8/2024	ProShare Advisors LLC	10,121	$0.21M	0.0%	N/A	0.019%
5/8/2024	Legacy Capital Group California Inc.	33,832	$0.70M	0.3%	N/A	0.065%
5/7/2024	Swiss National Bank	86,700	$1.79M	0.0%	N/A	0.166%
5/3/2024	Essex Investment Management Co. LLC	149,819	$3.10M	0.6%	+1.5%	0.288%
5/1/2024	Capstone Investment Advisors LLC	11,130	$0.23M	0.0%	N/A	0.021%
5/1/2024	Janney Montgomery Scott LLC	18,040	$0.37M	0.0%	+26.5%	0.035%
4/29/2024	China Universal Asset Management Co. Ltd.	9,393	$0.19M	0.0%	+129.9%	0.018%
4/9/2024	Woodstock Corp	30,778	$0.64M	0.1%	+38.3%	0.062%
3/21/2024	Healthcare of Ontario Pension Plan Trust Fund	137,000	$3.17M	0.0%	N/A	0.275%
2/22/2024	Sierra Summit Advisors LLC	22,613	$0.52M	0.2%	N/A	0.048%
2/20/2024	Quarry LP	3,000	$69K	0.0%	-75.0%	0.006%
2/15/2024	PFM Health Sciences LP	170,871	$3.95M	0.2%	N/A	0.363%
2/14/2024	Artia Global Partners LP	50,000	$1.16M	0.3%	N/A	0.106%
2/14/2024	Ghisallo Capital Management LLC	108,634	$2.51M	0.3%	N/A	0.231%
2/14/2024	Sectoral Asset Management Inc.	81,160	$1.88M	0.8%	-53.9%	0.172%
2/14/2024	Ratan Capital Management LP	45,000	$1.04M	0.7%	N/A	0.096%
2/13/2024	Tower Research Capital LLC TRC	4,724	$0.11M	0.0%	+36.0%	0.010%
2/13/2024	Bard Associates Inc.	14,600	$0.34M	0.1%	-23.6%	0.031%
2/12/2024	Scotia Capital Inc.	8,963	$0.21M	0.0%	-90.1%	0.019%
2/12/2024	Monashee Investment Management LLC	175,000	$4.04M	0.7%	N/A	0.372%
2/12/2024	TD Asset Management Inc	142,894	$3.30M	0.0%	+99.0%	0.304%
2/9/2024	Franklin Resources Inc.	4,640,651	$107.25M	0.1%	+11.8%	9.859%
2/9/2024	Trexquant Investment LP	48,760	$1.13M	0.0%	-53.4%	0.104%
2/9/2024	UBS Group AG	574,169	$13.27M	0.0%	+9.0%	1.220%
2/8/2024	Panagora Asset Management Inc.	80,780	$1.87M	0.0%	+7.4%	0.172%
2/8/2024	Nicholas Investment Partners LP	53,236	$1.23M	0.1%	N/A	0.113%
2/8/2024	First Turn Management LLC	317,010	$7.33M	1.1%	N/A	0.673%
2/8/2024	Essex Investment Management Co. LLC	147,541	$3.41M	0.7%	-28.8%	0.313%
2/7/2024	Jump Financial LLC	23,794	$0.55M	0.0%	-51.4%	0.051%
2/5/2024	Victory Capital Management Inc.	28,530	$0.66M	0.0%	N/A	0.061%
2/1/2024	New York State Common Retirement Fund	21,511	$0.50M	0.0%	+176.6%	0.046%
2/1/2024	Jennison Associates LLC	1,066,240	$24.64M	0.0%	N/A	2.265%
1/31/2024	Federated Hermes Inc.	674,824	$15.60M	0.0%	+194.0%	1.434%
1/30/2024	Strs Ohio	23,300	$0.54M	0.0%	-5.3%	0.050%
1/26/2024	Toth Financial Advisory Corp	5,000	$0.12M	0.0%	+42.9%	0.011%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	15,584	$0.36M	0.0%	+6.0%	0.033%
1/24/2024	DekaBank Deutsche Girozentrale	35,000	$0.82M	0.0%	N/A	0.074%
1/24/2024	China Universal Asset Management Co. Ltd.	4,085	$94K	0.0%	N/A	0.009%
1/16/2024	Legato Capital Management LLC	59,347	$1.37M	0.2%	-23.3%	0.126%
1/12/2024	FNY Investment Advisers LLC	1,210	$27K	0.0%	N/A	0.003%
1/8/2024	Woodstock Corp	22,253	$0.51M	0.1%	N/A	0.047%
1/1/2024	Deutsche Bank AG	21,764	$0.17M	0.0%	+4.0%	0.046%
11/22/2023	Graham Capital Management L.P.	30,042	$0.24M	0.0%	N/A	0.085%
11/15/2023	Scotia Capital Inc.	90,963	$0.73M	0.0%	+144.9%	0.258%
11/15/2023	Sectoral Asset Management Inc.	176,080	$1.41M	0.3%	-43.4%	0.499%
11/15/2023	Acuta Capital Partners LLC	300,128	$2.40M	1.6%	-21.4%	0.850%
11/15/2023	Adage Capital Partners GP L.L.C.	1,736,503	$13.88M	0.0%	-2.6%	4.918%
11/14/2023	Corton Capital Inc.	22,682	$0.18M	0.1%	N/A	0.064%
11/14/2023	Sherbrooke Park Advisers LLC	12,620	$0.10M	0.0%	N/A	0.036%
11/14/2023	Trexquant Investment LP	104,618	$0.84M	0.0%	N/A	0.296%
11/13/2023	Federated Hermes Inc.	229,535	$1.83M	0.0%	+456.3%	0.650%
11/9/2023	Essex Investment Management Co. LLC	207,160	$1.66M	0.3%	-1.3%	0.587%
11/9/2023	UBS Group AG	526,848	$4.21M	0.0%	+487.6%	1.492%
11/8/2023	HighTower Advisors LLC	252,972	$2.02M	0.0%	-15.3%	0.716%
11/8/2023	Janney Montgomery Scott LLC	17,500	$0.14M	0.0%	N/A	0.050%
11/7/2023	New York State Common Retirement Fund	7,776	$62K	0.0%	-50.4%	0.022%
11/7/2023	Barclays PLC	45,659	$0.37M	0.0%	+103.4%	0.129%
11/7/2023	Jump Financial LLC	48,968	$0.39M	0.0%	+318.5%	0.139%
10/27/2023	TD Asset Management Inc	71,800	$0.57M	0.0%	N/A	0.203%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	14,702	$0.12M	0.0%	N/A	0.042%
10/26/2023	Strs Ohio	24,600	$0.20M	0.0%	N/A	0.070%
10/24/2023	Bank of New York Mellon Corp	115,690	$0.92M	0.0%	+11.9%	0.331%
10/12/2023	Toth Financial Advisory Corp	3,500	$28K	0.0%	+250.0%	0.010%

Data available starting January 2016

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $8.91

$8.62

$9.33

50 Day Range

MA: $8.89

$7.58

$10.54

52 Week Range

Now: $8.91

$5.67

$30.99

Volume

649,284 shs

Average Volume

958,246 shs

Market Capitalization

$476.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.59

Who are the company insiders with the largest holdings of EyePoint Pharmaceuticals?: EyePoint Pharmaceuticals' top insider investors include:
Cormorant Asset Management, Lp (Major Shareholder)
Ew Healthcare Partners, LP (Major Shareholder)
Ye Liu (Director)
David Scott Jones (SVP)
Dario A Paggiarino (Insider)
Wendy F Dicicco (Director)
David R Guyer (Director)
Michael Craig Pine (Insider)
Learn More about top insider investors at EyePoint Pharmaceuticals.
Who are the major institutional investors of EyePoint Pharmaceuticals?: EyePoint Pharmaceuticals' top institutional shareholders include:
Deerfield Management Company L.P. Series C — 1.69%
Fiera Capital Corp — 1.30%
Fiera Capital Corp — 1.30%
Perceptive Advisors LLC — 1.23%
Point72 Asset Management L.P. — 1.21%
Millennium Management LLC — 1.11%
Learn More about top institutional investors of EyePoint Pharmaceuticals stock.
Which major investors are selling EyePoint Pharmaceuticals stock?: Within the last quarter, EYPT stock was sold by these institutional investors:
Millennium Management LLC
Federated Hermes Inc.
Canada Pension Plan Investment Board
Squarepoint Ops LLC
Legato Capital Management LLC
AQR Capital Management LLC
Quest Partners LLC
TD Asset Management Inc
During the previous year, company insiders that have sold EyePoint Pharmaceuticals company stock include:
Cormorant Asset Management, Lp (Major Shareholder)
Ew Healthcare Partners, LP (Major Shareholder)
Ye Liu (Director)
David Scott Jones (SVP)
Dario A Paggiarino (Insider)
Learn More investors selling EyePoint Pharmaceuticals stock.
Which major investors are buying EyePoint Pharmaceuticals stock?: Within the last quarter, EYPT stock was purchased by institutional investors including:
Point72 Asset Management L.P.
Cubist Systematic Strategies LLC
Deerfield Management Company L.P. Series C
Panagora Asset Management Inc.
Renaissance Technologies LLC
SG Americas Securities LLC
Perceptive Advisors LLC
Bank of New York Mellon Corp
During the previous year, these company insiders have bought EyePoint Pharmaceuticals stock:
Cormorant Asset Management, Lp (Major Shareholder)
Ew Healthcare Partners, LP (Major Shareholder)
Learn More investors buying EyePoint Pharmaceuticals stock.